Our verdict is Pathogenic. Variant got 10 ACMG points: 10P and 0B. PM2PP5_Very_Strong
The NM_201525.4(ADGRG1):c.-36+10587_-36+10601delCAACGGTTGCCAGGG variant causes a intron change. The variant allele was found at a frequency of 0.0000619 in 985,316 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Likely pathogenic (★★).
ADGRG1 (HGNC:4512): (adhesion G protein-coupled receptor G1) This gene encodes a member of the G protein-coupled receptor family and regulates brain cortical patterning. The encoded protein binds specifically to transglutaminase 2, a component of tissue and tumor stroma implicated as an inhibitor of tumor progression. Mutations in this gene are associated with a brain malformation known as bilateral frontoparietal polymicrogyria. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2014]
Verdict is Pathogenic. Variant got 10 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 16-57639373-CCAACGGTTGCCAGGG-C is Pathogenic according to our data. Variant chr16-57639373-CCAACGGTTGCCAGGG-C is described in ClinVar as [Likely_pathogenic]. Clinvar id is 127079.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
Review Status: criteria provided, single submitter
Collection Method: clinical testing
This sequence change falls in intron 1 of the ADGRG1 gene. It does not directly change the encoded amino acid sequence of the ADGRG1 protein. This variant is present in population databases (no rsID available, gnomAD 0.01%). This variant has been observed in individuals with restricted polymicrogyria (PMID: 24531968). It has also been observed to segregate with disease in related individuals. Algorithms developed to predict the effect of variants on protein structure and function are not available or were not evaluated for this variant. Experimental studies have shown that this variant affects ADGRG1 function (PMID: 24531968). For these reasons, this variant has been classified as Pathogenic. -
Feb 14, 2024
GeneDx
Significance: Likely pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing
Published functional studies suggest this variant results in decreased expression in the lateral cortex and decreases binding of RFX-family transcription factors (PMID: 24531968); In silico analysis supports that this variant does not alter splicing; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 24531968) -